◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › OPRX

OptimizeRx Corporation (OPRX) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Health Information Services · DATA UPDATED 2026-07-09

OptimizeRx Corporation (OPRX) operates in the Health Information Services industry and is headquartered in Waltham, United States with about 132 employees. Its market capitalization is roughly $118 million. In the fiscal year ended 2025-12-31, OPRX reported $109M in revenue and $5M in net income.

OptimizeRx Corporation operates as a digital healthcare technology company.

Interactive charts & full statements → Open the OPRX valuation workbench →

OPRX Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$109M$92M$72M$62M
Gross Profit$74M$59M$43M$39M
Operating Income (EBIT)$12M($6M)($18M)($12M)
Net Income$5M($20M)($18M)($11M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OPRX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$20M$32M$26M$29M$22M
Gross Profit$15M$24M$18M$19M$13M
Operating Income (EBIT)$0M$9M$2M$3M($2M)
Net Income($0M)$5M$1M$2M($2M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OPRX Free Cash Flow History

OPRX Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$177M$171M$183M$135M
Total Liabilities$49M$54M$57M$8M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OPRX viewer.

Other Companies in Health Information Services

← OPRTAll stocksOPTH →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.